NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:30 |
How to Get Your Paper Published |
Jiaywei Tsauo | Guangdong Provincial People's Hospital, China |
2 | 14:30-14:45 |
The Art of Transforming Ideas into Scientific Investigations |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
3 | 14:45-15:00 |
How I Updated My Writing Skills after Publishing My First Paper |
Chu-Hui Zeng | Zhongda Hospital, Southeast University, China |
4 | 15:00-15:15 |
Top Five Reasons for Writing Scientific Papers |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
5 | 15:15-15:55 |
Panelist
Ho-Young Song
Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China /
Jiaywei Tsauo
Guangdong Provincial People's Hospital, China /
Chu-Hui Zeng
Zhongda Hospital, Southeast University, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China /
Xi Li
The Fifth Affiliated Hospital of Sun Yat-sen University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Sequential TACE and PVE before Right Pemihepatectomy in Patients with HCC |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
2 | 16:12-16:24 |
Surgical Treatment of HCC with Portal Vein Tumor Thrombus - Progress and Perspectives |
Shu-Qun Cheng | Eastern Hepatobiliary Surgery Hospital, China |
3 | 16:24-16:36 |
TARE for Unresected HCC with Portal Vein Invasion: Which Patient to Treat? |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
4 | 16:36-16:48 |
Precision Radiotherapy and Immune-targeted Therapeutic Strategies in Hepatocellular Carcinoma |
Wei-Hu Wang | Beijing Cancer Hospital, China |
5 | 16:48-17:00 |
ICIs and Anti-VEGF Antibody/TKIs with or without TACE as First-line Treatment for Advanced HCC (CHANCE2201): A Target Trial Emulation Study |
Hai-Tao Zhao | Peking Union Medical College Hospital, China |
6 | 17:00-17:12 |
A Nationwide Target Trial Emulation on the Treatment of Patients with HCC and Main Trunk PVTT Using 125I Irradiation Stents and Combined Therapeutic Approaches (PATENCY II) |
Jian Lu | Zhongda Hospital, Southeast University, China |
7 | 17:12-17:30 |
Panelists
Flavio G. Rocha
Oregon Health and Science University, USA /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Shu-Qun Cheng
Eastern Hepatobiliary Surgery Hospital, China /
Ajit K. Yadav
Sir Ganga Ram Hospital, Delhi, India /
Wei-Hu Wang
Beijing Cancer Hospital, China /
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China
|